Dsruptive Subdermals

Sections Remote Monitoring
Technologies Sensors
Funding 💰
Total €400K
Select investors Nordic Group
Key people 🧑🤝🧑
- Juanjo Tara - Co-founder & CEO
- Chris Moore - Co-founder & Chairman of the Board & Strategy
- Alejandro Pino España - Software Lead
- Ismael Sánchez López - Hardware Engineer
Highlights ⭐
- Clinically tested tech: In June 2021, DSruptive concluded a world-first clinical study using injectable implants to track body temperature and has found that its subdermal implants have comparable results to existing clinical methods for temperature measurement. 🔗
- COVID-19 response: Dsruptive Subdermals has created a microchip that allows users to carry their COVID vaccine passport under their skin.
- Media love: The company has been featured in several outlets, including Insider, El Correo, ABC Economía, Diario de Almeria, Controcorrente, SIFTED, Techradar, La Vanguardia, ABC News, and more. 🔗
Video ▶️
Awards & Recognitions 🏆
Quotes 💬
“
We have followed DSruptive, its evolving technology, and its potential to harness a personalisation of healthcare, for a number of years. We decided that now is an ideal time to step in and help accelerate the business through an active involvement. I am impressed by the business and technical proficiency of DSruptive’s seasoned team. The founders are leaders in their field and are already serving multiple international clients with advisory services relating to implantable platforms. This type of technology has huge global potential. With this team, DSruptive is in excellent hands.
— Chris Moore, Managing Director of Nordic Group 🔗
Last update: March 17, 2023
Disclaimer: We can not guarantee that the information on this page is 100% correct. more